News archive
News Archive Navigation
icon
News Archive Navigation Language
Showing 640 results
January 2020
-
Media ReleasePublic-Private Collaboration Commits to Accelerate Access to Health Services in Africa, Reaching 1.7 Million PeopleHealthcare companies and philanthropies to fund training of thousands of community health workers as part of larger initiative led by Last Mile Health and Living Goods to advance universal health…
-
Media ReleasePublic-Private Collaboration Commits to Accelerate Access to Health Services in Africa, Reaching 1.7 Million People
December 2019
-
Media ReleaseNovartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polypsEAST HANOVER, N.J., Dec. 11, 2019 /PRNewswire/ -- The submission is based on positive results from the Phase III POLYP 1 and POLYP 2 studies of Xolair in adults with chronic rhinosinusitis with…
-
Media ReleaseNovartis announces FDA filing acceptance of Xolair® (omalizumab) for treatment of nasal polyps
-
Media ReleaseNovartis Kymriah® demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting- Efficacy in DLBCL confirmed results seen in the pivotal trial despite treatment of a broader population, including older and more heavily pretreated patients1-3- Fewer known CAR-T cell therapy…
-
Media ReleaseNovartis Kymriah® demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting
November 2019
-
Media ReleaseNew Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell diseaseSickle cell pain crises are unpredictable, severe events associated with life-threatening complications(1)Adakveo reduced the annual rate of sickle cell pain crises by 45% compared to placebo (1.63…
-
Media ReleaseNew Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
-
Media ReleaseNovartis launches PsO at Work with music icon Cyndi Lauper to bring to life the impact psoriasis can have in the workplace- PsO at Work provides a critical resource to help the more than 8 million Americans with psoriasis balance the demands of their jobs with managing their symptoms(1)- Lauper will highlight her PsO at…
-
Media ReleaseNovartis launches PsO at Work with music icon Cyndi Lauper to bring to life the impact psoriasis can have in the workplace
Pagination
- ‹ Previous page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- …
- 54
- › Next page